Cause-Specific Mortality Among Patients With Psychosis: Disentangling the Effects of Age and Illness Duration

Hennekens, 2005, Schizophrenia and increased risks of cardiovascular disease, Am Heart J, 150, 1115, 10.1016/j.ahj.2005.02.007 Saha, 2007, A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?, Arch Gen Psychiatry, 64, 1123, 10.1001/archpsyc.64.10.1123 Palmer, 2005, The lifetime risk of suicide in schizophrenia: a reexamination, Arch Gen Psychiatry, 62, 247, 10.1001/archpsyc.62.3.247 Black, 1988, Age, mortality and chronic schizophrenia, Schizophr Res, 1, 267, 10.1016/0920-9964(88)90002-3 Hasnain, 2009, Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications, Prim Care Diabetes, 3, 5, 10.1016/j.pcd.2008.10.005 Kelly, 2010, Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study, J Clin Psychiatry, 71, 304, 10.4088/JCP.08m04718yel Mitchell, 2009, Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies, Br J Psychiatry, 194, 491, 10.1192/bjp.bp.107.045732 Bushe, 2010, Mortality in schizophrenia: a measurable clinical endpoint, J Psychopharmacol, 24, 17, 10.1177/1359786810382468 Lawrence, 2010, The epidemiology of excess mortality in people with mental illness, Can J Psychiatry, 55, 752, 10.1177/070674371005501202 Mortensen, 1993, Mortality and causes of death in first admitted schizophrenic patients, Br J Psychiatry, 163, 183, 10.1192/bjp.163.2.183 Termorshuizen, 2012, Psychosis and suicide risk by ethnic origin and history of migration in the Netherlands, Schizophr Res, 138, 268, 10.1016/j.schres.2012.03.035 Rabe-Hesketh, 2005, 181 Ng, 2012, Cancer mortality in patients with psychiatric diagnoses: a higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer, Soc Psychiatry Psychiatr Epidemiol Hodgson, 2010, Cancer and schizophrenia: is there a paradox?, J Psychopharmacol, 24, 51, 10.1177/1359786810385489 Batty, 2012, Impact of mental health problems on case fatality in male cancer patients, Br J Cancer, 106, 1842, 10.1038/bjc.2012.150 Chou, 2011, The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study, Schizophr Res, 129, 97, 10.1016/j.schres.2011.02.018 Ji, 2012, Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden, Schizophr Bull Osborn, 2007, Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database, Arch Gen Psychiatry, 64, 242, 10.1001/archpsyc.64.2.242 Whitley, 2012, Psychiatric disorder as a risk factor for cancer: different analytic strategies produce different findings, Epidemiology, 23, 543, 10.1097/EDE.0b013e3182547094 Kiviniemi, 2010, Regional differences in five-year mortality after a first episode of schizophrenia in Finland, Psychiatr Serv, 61, 272, 10.1176/appi.ps.61.3.272 Cohen, 2006, Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment, Eur Neuropsychopharmacol, 16, 187, 10.1016/j.euroneuro.2005.09.003 Ryan, 2003, Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia, Am J Psychiatry, 160, 284, 10.1176/appi.ajp.160.2.284 Thakore, 2002, Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia, Int J Obes Relat Metab Disord, 26, 137, 10.1038/sj.ijo.0801840 Fernandez-Egea, 2009, Metabolic profile of antipsychotic-naive individuals with non-affective psychosis, Br J Psychiatry, 194, 434, 10.1192/bjp.bp.108.052605 Kirkpatrick, 2012, Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits?, Schizophr Bull, 38, 280, 10.1093/schbul/sbq058 Tiihonen, 2009, 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study), Lancet, 374, 620, 10.1016/S0140-6736(09)60742-X Enger, 2004, Serious cardiovascular events and mortality among patients with schizophrenia, J Nerv Ment Dis, 192, 19, 10.1097/01.nmd.0000105996.62105.07 Harris, 1998, Excess mortality of mental disorder, Br J Psychiatry, 173, 11, 10.1192/bjp.173.1.11 De Hert, 2011, Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care, World Psychiatry, 10, 52, 10.1002/j.2051-5545.2011.tb00014.x Papanastasiou, 2011, Schizophrenia as segmental progeria, J R Soc Med, 104, 475, 10.1258/jrsm.2011.110051 Fernandez-Egea, 2011, Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis: a test of the accelerated aging hypothesis, Psychosom Med, 73, 643, 10.1097/PSY.0b013e318230343f Jin, 2011, Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms, Schizophr Res, 125, 295, 10.1016/j.schres.2010.10.029 Gale, 2012, Association of mental disorders in early adulthood and later psychiatric hospital admissions and mortality in a cohort study of more than 1 million men, Arch Gen Psychiatry, 69, 823, 10.1001/archgenpsychiatry.2011.2000